− Patients Receiving Investigational ALN-AGT Experienced Dose-Dependent Reductions in Blood Pressure, Confirming Potential for RNAi-Mediated Angiotensinogen (AGT) Silencing as a Novel Therapeutic Approach for Hypertension – − Durable AGT Knockdown Through 12 Weeks Supports a Once Quarterly or Potentially Less Frequent Dosing Regimen – − ALN-AGT Generally Well Tolerated, with […]
Rhythm
Kardium Performs First Cases with the Globe® Positioning System
New 3D mapping and navigation feature allows for high-definition mapping of the full atrium VANCOUVER, British Columbia–(BUSINESS WIRE)–Kardium is pleased to announce the first clinical use of the Globe Positioning System (GPS™) – the new 3D mapping and navigation feature of its flagship product, the Globe® Mapping and Ablation System. […]
UNC Medical Center First in the Carolinas to Treat Heart Failure Patients Using Breakthrough CCM Therapy
Innovative minimally-invasive therapy is proven to help people with heart failure feel better CHAPEL HILL, N.C.–(BUSINESS WIRE)–UNC Medical Center today announced it is among the first hospitals in the United States and the first hospital in the Carolinas to use CCM® therapy, delivered by the Optimizer® system, to treat patients suffering from heart failure. […]
CB Scientific, Inc. (CBSC) Announces Definitive Agreement to Acquire Commercial Ambulatory ECG Device Manufacturer Datrix, LLC
Acquisition will expand Ambulatory Remote Cardiac ECG Monitoring product technology offering and outreach into US and international markets ESCONDIDO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — via InvestorWire – CB Scientific. Inc. (OTC:CBSC) (“CBSC” or the “Company”), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring […]
Nanowear Receives FDA 510(k) Clearance for SimpleSENSE, a Cloth-Based Wearable Remote Diagnostic Monitoring Platform
SimpleSENSE provides a continuous, simultaneous, and synchronous assessment of the heart, lungs, and upper vascular system without the need for an in-person doctor’s visit NEW YORK, Nov. 11, 2020 /PRNewswire/ — Nanowear www.nanowearinc.com, the leading connected-care and remote diagnostic platform, today announced it has received FDA Class II 510(k) clearance for a first-of-its-kind cloth-based […]
Former CIA Senior Medical Officer Gains CE Mark for HeartHero’s Revolutionary AED “Elliot,” Taking on New Mission Saving Lives and Disrupting the Cardiac Industry
With its newly-approved CE Mark, Denver-based company HeartHero is poised on the front lines to combat the global threat of Cardiac Death. Created by a team of medical experts and partners, Elliot’s affordable price tag and portable size help place lifesaving technology within arm’s reach for anyone, anywhere. DENVER–(BUSINESS WIRE)–Today, […]
GBT Tokenize to Add Blood Pressure Measurement Feature to qTerm Device
Version II Aim to Release Q1/2021 SAN DIEGO, Nov. 05, 2020 (GLOBE NEWSWIRE) — GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”, or the “Company”), announced that its joint Venture GBT Tokenize Corp (“GBT/Tokenize”) is currently developing an additional feature for its qTerm device. The additional feature will be a blood […]
ABBOTT INTRODUCES NEXT-GENERATION 3D CARDIAC MAPPING PLATFORM IN EUROPE AND AUSTRALIA
– The EnSite™ X EP System is a new cardiac mapping system designed from electrophysiologist input to optimize cardiac ablation procedures – System offers electrophysiologists a new platform of options to provide consistent performance, regardless of the patient’s cardiac anatomy ABBOTT PARK, Ill., Nov. 2, 2020 — Abbott today announced it […]
Masimo Announces Limited Market Release of Radius VSM™
Versatile, Wearable Continuous Monitoring Solution Provides Masimo SET® Pulse Oximetry, Proprietary Noninvasive Blood Pressure, Body Temperature, Respiration Rate, and Electrocardiography NEUCHATEL, Switzerland–(BUSINESS WIRE)–Masimo (NASDAQ: MASI) announced today that Radius VSM™, a wearable, tetherless vital signs monitor, has received CE marking and is being released in limited European markets. The versatile, expandable Radius […]
Boston Scientific Initiates Trial to Evaluate WATCHMAN FLX™ Left Atrial Appendage Closure Device as First-Line Treatment for People at Risk of Stroke
Trial to study next-generation device as treatment alternative to NOACs for broader population of patients with non-valvular atrial fibrillation MARLBOROUGH, Mass., Oct. 29, 2020 /PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) has initiated the CHAMPION-AF clinical trial to evaluate the safety and efficacy of the WATCHMAN FLX™ Left Atrial Appendage Closure (LAAC) Device […]



